More News

14 Mar 2007 Kedrion and ProMetic Form Strategic Alliance to Develop Orphan Drugs from Plasma
14 Mar 2007 Maxygen Announces End of Co-Development Agreement
13 Mar 2007 Schering-Plough to Acquire Organon BioSciences
13 Mar 2007 Cangene Receives an Approvable Letter From the FDA for Human Growth Hormone
13 Mar 2007 Oxford Biomedica To Acquire Oxxon Therapeutics
13 Mar 2007 Takeda to Acquire Paradigm Therapeutics
12 Mar 2007 Teva Receives First U.S. Approval For Generic UNIRETIC(R) Tablets
10 Mar 2007 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
10 Mar 2007 SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
09 Mar 2007 Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
09 Mar 2007 Teva Receives Approval For Generic Dostinex(R) Tablets
08 Mar 2007 Stemline Expands its Oncology Pipeline with Acquisition of Clinically Active Compound Directed to "Cancer Stem Cell" Target
08 Mar 2007 ZymoGenetics Provides Update on rhThrombin Development Plans
07 Mar 2007 Clinquest Group and TNO sign licensing agreement on protein for inflammatory disorders
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
07 Mar 2007 ProNAi and Novosom AG Announce Collaboration to Enable Delivery of DNAi-based Cancer Therapeutics
07 Mar 2007 Kyowa Hakko Kogyo Co., Ltd. Licenses its in-house developed antibody KW-2871 targeting malignant melanoma to Life Science Pharmaceuticals in the US.
07 Mar 2007 Nautilus Biotech and HanAll Pharmaceutical announce license agreement to develop three Nautilus Biotech products in South Korea
07 Mar 2007 Amarin Expands Neurology Pipeline With Epilepsy Product Candidate
07 Mar 2007 Avalon Pharmaceuticals and Merck & Co., Inc. Establish a Drug Discovery, Development and Commercialization Collaboration
06 Mar 2007 New studies indicate GSK's pre-pandemic influenza vaccine can protect against different strains of H5N1
06 Mar 2007 Affectis Pharmaceuticals AG Announces Extension of Research Collaboration with Mitsubishi Pharma
06 Mar 2007 Lilly Announces Acquisition of Hypnion
06 Mar 2007 Biocryst And Shionogi Establish Collaboration In Japan
06 Mar 2007 YM BioSciences completes enrolment of AeroLEF(TM) Phase IIB pain trial

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top